IRIS
LANDRISCINA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.955
EU - Europa 6.186
AS - Asia 2.805
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 14
AF - Africa 1
Totale 16.003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.925
IE - Irlanda 2.286
CN - Cina 2.055
UA - Ucraina 1.558
SE - Svezia 958
IT - Italia 381
SG - Singapore 289
FI - Finlandia 278
TR - Turchia 278
FR - Francia 271
DE - Germania 170
GB - Regno Unito 138
IN - India 135
BE - Belgio 41
RU - Federazione Russa 29
CZ - Repubblica Ceca 25
NL - Olanda 22
CA - Canada 21
EU - Europa 18
VN - Vietnam 13
JP - Giappone 11
AU - Australia 10
AR - Argentina 9
AT - Austria 9
BR - Brasile 7
IR - Iran 6
CL - Cile 5
ES - Italia 5
MX - Messico 4
NZ - Nuova Zelanda 4
CR - Costa Rica 3
HK - Hong Kong 3
ID - Indonesia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
LT - Lituania 2
PL - Polonia 2
AL - Albania 1
AM - Armenia 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 16.003
Salva come PNG Salva come JPEG
Città #
Dublin 2.284
Chandler 1.338
Jacksonville 1.109
Dearborn 754
Nyköping 643
Nanjing 580
Princeton 248
Beijing 242
Nanchang 221
Ashburn 219
Wilmington 216
San Mateo 199
New York 182
Singapore 180
Boardman 144
Shenyang 115
Ann Arbor 111
Kunming 109
Des Moines 106
Hebei 106
Helsinki 91
Tianjin 81
Munich 80
Woodbridge 78
Jiaxing 77
Changsha 67
Los Angeles 48
Jinan 47
Hangzhou 46
Foggia 40
Brussels 39
Guangzhou 36
Seattle 29
Zhengzhou 27
Ningbo 24
Washington 23
Brno 22
Auburn Hills 19
Norwalk 19
Lanzhou 18
Shanghai 18
Taizhou 18
London 15
Bari 14
Changchun 14
Orange 14
Fuzhou 13
Hilden 13
Palermo 13
Dong Ket 12
Falls Church 12
Pune 12
Redwood City 11
Saint Petersburg 11
Rome 10
Wuhan 10
Buenos Aires 9
Matera 9
Vienna 9
Augusta 8
Hefei 8
Toronto 8
Borås 7
San Severo 7
Shenzhen 7
Kocaeli 6
Philadelphia 6
Stevenage 6
Chicago 5
Chieti 5
Hobart 5
Milan 5
Monza 5
Potenza 5
Xuzhou 5
Auckland 4
Avigliano 4
Bacoli 4
Edmonton 4
Leawood 4
Phoenix 4
Rockville 4
San Giovanni Rotondo 4
Shaoxing 4
Turin 4
Andria 3
Casale sul Sile 3
Cologne 3
Jakarta 3
Naples 3
Napoli 3
Nuremberg 3
Olomouc 3
Palombara Sabina 3
Paris 3
Rui'an 3
Simi Valley 3
São Paulo 3
Wuxi 3
Amsterdam 2
Totale 10.436
Salva come PNG Salva come JPEG
Nome #
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 120
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits 112
Adjuvant treatment for EGFR-mutated non-small cell lung cancer: Do we have a major breakthrough? 110
THE CALCIUM-BINDING PROTEIN S100A13 CORRELATES WITH AN ANGIOGENIC PHENOTYPE IN MALIGNANT MELANOMA 105
TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells 104
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 104
Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine. 103
FUNCTIONAL CHARACTERIZATION OF TRAP1 PATHWAY IN MULTIDRUG RESISTANCE IN HUMAN COLORECTAL CARCINOMA 100
Ruolo del signaling dell’EGF nel fenotipo angiogenetico del carcinoma indifferenziato della tiroide: implicazioni terapeutiche 100
Modulazione della MnSOD con LPS e ferro in HCC di ratto. 99
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 98
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 96
Trap1, a novel antiapoptotic gene responsible for multidrug resi stance in human colorectal carcinoma cells. 95
Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells. 95
Tripla modulazione del 5-Fluorouracile (5-FU) con Methotrexate (MTX), Acido Folinico (FA) e Cisplatino (CDDP) nella terapia dell’adenocarcinoma gastrico in fase avanzata: studio di fase II 94
The role of human chorionic gonadotropin as tumor marker: Biochemical and clinical aspects 93
TRAP1 favor glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 93
Cooperation between FGF1 and a soluble form of the notch ligand, Jagged-1, is required for a cell transformation. 92
Gli inibitori della retrotrascrittasi inducono l'espressione di TPO e Tireoglobulina in colture primarie di carcinoma indifferenziato della tiroide 92
Altered gene expression of MnSOD in Hepatocarcinomas. 90
Copper Induces the Assembly of a Multiprotein Aggregate Implicated in the Release of FGF1 in Response to Stress. 89
IRON REQUIREMENT FOR MnSOD GENE ACTIVATION IN MAMMALIAN CELLS. 89
RE-INDUCTION OF CELL DIFFERENTIATION AND 131I UPTAKE IN A POORLY-DIFFERENTIATED THYROID TUMOUR IN RESPONSE TO THE REVERSE TRANSCRIPTASE INHIBITOR NEVIRAPINE 89
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 89
Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report. 88
Meccanismi molecolari coinvolti nell’azione differenziante della nevirapina nel carcinoma indifferenziato della tiroide. 87
BRAF V600E and KRAS G12R mutations correlate with Sunitinib resistance in thyroid cancer cell lines. 87
The Nrf2 transcription factor contributes to the induction of alpha-class GST isoenzymes in liver of acute cadmium or manganese intoxicated rats: comparison with the toxic effect on NAD(P)H:quinone reductase. 86
Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. 86
TRAP1, a novel antiapoptotic gene responsible for multidrug resistance. 86
Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer. 85
Anti-tumor Activity of non-Nucleosidic Reverse Transcriptase Inhibitors 85
TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma 85
A role of endogenous Reverse Transcriptase activity in embryo development and in tumor cell growth and differentiation 84
Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines 84
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP-6 84
Amlexanox reversibly inhibits cell migration and proliferation and induces the Src-dependent disassembly of actin stress fiber in vitro. 83
PRECLINICAL EVIDENCES ON THE ACTIVITY OF EGFR1 INHIBITORS IN POORLY-DIFFERENTIATED THYROID CARCINOMA CELLS 83
The levels of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanism and clinical implications. 82
TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells 82
THE REVERSE TRANSCRIPTASE INHIBITOR NEVIRAPINE RE-INDUCES CELL DIFFERENTIATION AND 131I UPTAKE IN A POORLY-DIFFERENTIATED THYROID TUMOUR 82
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6 82
COMPARATIVE GENE EXPRESSION PROFILING OF TOBACCO-ASSOCIATED HPV-POSITIVE VERSUS NEGATIVE ORAL SQUAMOUS CARCINOMA CELL LINES. 82
Schedule-Dependent Activity of the 5-Fluorouracil and Irinotecan Combination in the Treatment of Human Colorectal Cancer: In Vitro Evidences and a Phase I Dose-escalating Clinical Trial. 82
Trap-1, a novel antiapoptotic gene responsible for resistance to chemotherapeutic agents in human colorectal carcinoma. 81
bFGF in the angiogenesis of human colorectal cancer. 81
Amlexanox induces the reversible attenuation of F-acitin stress fibers. 81
TRAP1-dependent regulation of p70S6K is involved in the attenuation of protein synthesis and cell migration: Relevance in human colorectal tumors. 81
RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study 81
Preparation of a monoclonal antibody against rat MnSOD, using a COOH-terminal peptide. 80
NOTCH SIGNALLING MODULATES HYPOXIA-INDUCED NEUROENDOCRINE DIFFERENTIATION OF HUMAN PROSTATE CANCER CELLS 80
The precursor but not the mature form of IL1alpha blocks the release of FGF1 in response to heat shock. 79
Induction of MnSOD by ethanol administration in rat liver. 79
TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 79
Diethyldithiocarbamate treatment up-regulates manganese superoxidedismutase gene expression in rat liver. 78
Nevirapine restores hormone sensitivity in undifferentiated androgen-refractory prostate carcinoma cells 78
Inhibition of cell proliferation by amlexanox correlates with cortactin phosphorylation and cyclin D1 down-regulation independent of MAPK activation. 78
bFGF LEVELS IN COLORECTAL CANCER: PRELIMINARY REPORT. 78
Il Sunitinib inibisce la proliferazione di linee di carcinoma tiroideo BRAF e KRAS wild-type. 78
Sorcin induces a drug-resistant phenotype in human colorectal cancer through the modulation of Ca2+ homeostasis. 78
Analysis of the mutational status of the BRAF oncogene in familiar non-medullary thyroid carcinomas. 78
TRAP1 controls cell cycle progression through the regulation of CDK1 and MAD2 expression/ubiquitination in human breast, colon and lung carcinomas. 78
Variation of MnSOD in rat experimental tumors detected by western blot analysis with a new monoclonal antibody. 77
Jagged-1-dependent cell chord formation in vitro is modified by src and is resistant to the destabilization of actin stress fibers. 77
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma 77
TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways 77
ALK rearrangement in specific subtypes of lung adenocarcinoma: immunophenotypic and morphological features 77
S100A13 is a new angiogenic marker in human melanoma 76
Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1 76
TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma 76
TRAP1 controls cell cycle G2–M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 76
The non-classical export routes: FGF1 and IL-1alpha point the way. 75
Biological mechanisms and clinical significance of angiogenesis in colorectal cancer. 75
Functional characterization of TRAP1 pathway in multidrug resistance in human colorectal carcinoma. 75
Aumentata espressione della manganese superossidodismutasi in tumori cerebrali neuroectodermici: un nuovo marcatore di progressione? 75
Evaluation of Glucose Uptake in Normal and Cancer Cell Lines by Positron Emission Tomography 75
Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. 73
MECHANISM OF DEFECTIVE GENE EXPRESSION OF MNSOD IN CANCER CELLS. 73
REVERSE TRANSCRIPTASE INHIBITORS INDUCE CELL DIFFERENTIATION AND ENHANCE THE IMMUNOGENIC PHENOTYPE IN HUMAN RENAL CELL CARCINOMA 73
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer 72
TRAP1 favors glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 72
Protein folding does not prevent the non-classical export of FGF1 and S100A13. 71
S100 calcium binding protein A13 71
TRAP1 represent a key mediator of stemness and glycolytic metabolism in colorectal cancer cells 71
TRAP1 downregulation in human ovarian cancer enhances invasion and Epithelial-Mesenchymal Transition 71
Monoclonal antibody 35.8 recognizes human, mouse and rat MnSOD in western blot and immunostaining. 70
Adaptation to oxidative stress, chemoresistance and cell survival 70
Treatment of patients with advanced gastric carcinoma with 5-fluorouracil-based or cisplatin-based regimen: two parallel phase II studies. 70
The role of Interferon-a2b in the treatment of advanced colorectal cancer with Folinic acid and 5-Fluorouracil: a randomized study. 70
TMZ and PCV in unresectable high grade gliomas: a retrospective comparison between two common schedules. 70
Neoadjuvant treatment of metastatic liver disease with irinotecan and 5-fluorouracil (5-FU) plus folinic acid (L-FA) in colorectal cancer patients. 70
Rapid long-lasting biochemical and radiological response to sorafenib in a case of advanced hepatocellular carcinoma 70
Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma 70
TRAP1 is a novel molecular target in BRAF-driven human colorectal carcinomas 70
The reciprocal regulation between TRAP1 and BRAF is responsible for control of cell cycle progression and modulation of mitochondrial apoptotic pathway. 70
The role of EGF signaling in the progression toward a poorly-differentiated mesenchymal-like phenotype in thyroid carcinoma cells 69
S100A13, a new marker of angiogenesis in brain tumors. 69
Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma 69
Bolus and infusional 5-fluorouracil combined with cisplatin in advanced gastric cancer. 68
Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. 68
Totale 8.216
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.126 0 0 0 0 435 473 485 44 304 41 296 48
2020/20211.864 273 12 226 20 241 133 297 84 273 279 4 22
2021/20221.192 193 11 15 19 60 20 37 99 177 119 51 391
2022/20235.757 467 210 271 341 384 541 58 438 2.740 35 124 148
2023/2024971 187 42 58 44 100 285 39 68 5 19 4 120
2024/2025634 162 99 78 194 101 0 0 0 0 0 0 0
Totale 16.532